  Hepatic fibrosis<disease> is a common pathological basis of liver cirrhosis and hepatocellular carcinomas. So , prevention and treatment of liver fibrosis<disease> is one of the crucial therapeutic goals in hepatology. Organic selenium , glutathione or probiotics supplementation could ameliorate hepatic fibrosis<disease> , respectively. The purpose of this study is to develop a novel selenium-glutathione-enriched probiotics ( SGP) and to investigate its protective effect on CCl